A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Unlike other slimming injections, the jab manufactured by US pharmaceutical giant Eli Lilly not only suppresses the appetite ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...
18h
Hosted on MSNWeight-loss jabs ‘slash alcohol cravings and curb heavy drinking’Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss ...
Shares of Novo Nordisk (NVO) are up 6% in pre-market trading after a FDA drug shortage notice indicated that a shortage of several versions of ...
The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.
The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.
Stand-up shows from Josh Johnson, Rosebud Baker, Craig Ferguson and others investigate Kendrick Lamar’s halftime show, motherhood and the politics of dumplings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results